Related Experiment Videos
Long-term results of Molteno implants
1Corneal Consultants of Indiana, Indianapolis, USA.
Ophthalmic Surgery
|March 1, 1995
Summary
Molteno implants effectively lowered intraocular pressure (IOP) in glaucoma patients. The study found a high success rate for IOP control, though complications like graft failure occurred.
Area of Science:
- Ophthalmology
- Glaucoma Surgery
- Medical Devices
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Elevated intraocular pressure (IOP) is a primary risk factor for glaucoma progression.
- Molteno implants are a surgical option for managing refractory glaucoma.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of Molteno implants in glaucoma management.
- To assess the impact of Molteno implants on intraocular pressure (IOP) control.
- To identify common complications associated with Molteno implants.
Main Methods:
- Retrospective review of 76 Molteno implants in 72 eyes.
- Minimum follow-up of 18 months.
- Data collection on pre- and post-operative intraocular pressure (IOP).
Main Results:
- Mean IOP reduced from 35.31 mm Hg preoperatively to 14.0 mm Hg postoperatively (mean follow-up 33.27 months).
- Success rate (IOP 5-21 mm Hg) was 74%, rising to 79% when including cases of hypotony without vision loss.
- Frequent complications included corneal graft failure, filtration tube blockage, choroidal effusion, and hyphema/vitreous hemorrhage.
Conclusions:
- Molteno implants demonstrate significant efficacy in lowering IOP for glaucoma patients.
- While effective, Molteno implants are associated with specific surgical complications that require monitoring.
- Long-term IOP control is achievable with Molteno implants, but careful patient selection and management are crucial.